Altria Non-GAAP EPS of $1.52 beats by $0.01, revenue of $5.44B beats by $130M (MO:NYSE)
Altria reported Q3 Non-GAAP EPS of $1.52, exceeding estimates by $0.01, with revenue of $5.44B, up 3.4% year-over-year and $130M above expectations. The company expects 2026 adjusted diluted EPS to range from $5.66 to $5.74, compared to the consensus of $5.68, indicating 4.5% to 6.0% growth from 2025's $5.42.
How this was made
The 30-second read
Why it matters
The beat may prompt short-term buying interest and could influence related stocks in the consumer staples space.
Market read
Altria's earnings beat offers a short-term trading opportunity for the stock and may affect the broader tobacco sector.
What to watch
Potential impact of upcoming FDA regulations and shifting consumer preferences could temper upside.
Background
Altria's earnings release provides the latest financial performance metrics for the quarter.
Ticker impact
Altria reported Q3 Non-GAAP EPS of $1.52, beating expectations by $0.01 and revenue of $5.44B, up 3.4% YoY, beating by $130M.
likely modest upside as market prices in the earnings beat
Both EPS and revenue exceeded consensus, and Altria is a large-cap consumer staple; investors typically reward such beats.
Market effects
Tobacco sector may see slight rally as a major player posted a beat.
U.S. consumer staples index could receive a modest lift.
Limited to markets tracking U.S. tobacco stocks; no broad global impact.
Counterpoint
The beat is marginal; investors may remain cautious given regulatory headwinds on tobacco.
Key entities
- CompanyAltria Group, Inc.
U.S. tobacco and wine company reporting Q3 results.



